Mark W. Hahn, CFO: Verona Pharma VRNA Sell · Filed 24/10/22

Trade details

Type: Insider sale
Amount: $1,093,808.64
Shares · price: 249,728 sh · $4.38 a share
Held after: 14,089,960 sh
Stock: Verona Pharma VRNA
Person: Mark W. HahnCFO
Trade date: 24/10/18
Filed: 24/10/22
Days to filing: 4 days

Sold 1.7% of holdings

Share of holding sold: 1.7%

Verona Pharma trades, last 26 weeks

What else happened in Verona Pharma around then

Filed or reported within 30 days of the trade day · 24/09/18~24/11/17

Mark W. Hahn's recent trades

Mark W. HahnCFO
Sell10b5-1 planVerona Pharma
Sell10b5-1 plan
Verona Pharma
VRNA
$2.7M
208,912 sh
$2.7M
Filed 25/08/05
Traded 25/08/01
Mark W. HahnCFO
Sell10b5-1 planVerona Pharma
Sell10b5-1 plan
Verona Pharma
VRNA
$4.6M
400,000 sh
$4.6M
Filed 25/06/13
Traded 25/06/11
Mark W. HahnCFO
Sell10b5-1 planVerona Pharma
Sell10b5-1 plan
Verona Pharma
VRNA
$1.9M
204,864 sh
$1.9M
Filed 25/05/29
Traded 25/05/29
Mark W. HahnCFO
Sell10b5-1 planVerona Pharma
Sell10b5-1 plan
Verona Pharma
VRNA
$1.5M
162,704 sh
$1.5M
Filed 25/05/29
Traded 25/05/28
Mark W. HahnCFO
Sell10b5-1 planVerona Pharma
Sell10b5-1 plan
Verona Pharma
VRNA
$309.1K
32,432 sh
$309.1K
Filed 25/05/29
Traded 25/05/27

Mark W. Hahn, CFO — sold $1.1M of Verona Pharma VRNA · 1.7% of holdings · 10b5-1 plan | Whalegun